Novel Hydrazide-Hydrazones Bearing a Benzimidazole Ring: Design, Synthesis, and Evaluation of Inhibitor Properties Against CA I and CA II Isozymes

IF 3.3 4区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Chemical Biology & Drug Design Pub Date : 2024-11-30 DOI:10.1111/cbdd.70025
Ayşen Işık, Ulviye Acar Çevik, Ismail Celik, Kaan Küçükoğlu, Hayrunnisa Nadaroglu, Hayrani Eren Bostancı, Yusuf Özkay, Zafer Asım Kaplancıklı
{"title":"Novel Hydrazide-Hydrazones Bearing a Benzimidazole Ring: Design, Synthesis, and Evaluation of Inhibitor Properties Against CA I and CA II Isozymes","authors":"Ayşen Işık,&nbsp;Ulviye Acar Çevik,&nbsp;Ismail Celik,&nbsp;Kaan Küçükoğlu,&nbsp;Hayrunnisa Nadaroglu,&nbsp;Hayrani Eren Bostancı,&nbsp;Yusuf Özkay,&nbsp;Zafer Asım Kaplancıklı","doi":"10.1111/cbdd.70025","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>In this study, we propose identifying potential novel compounds targeting carbonic anhydrase I and II. Herein, we have designed and synthesized new benzimidazole-hydrazide-hydrazones derivatives (<b>4a-4r</b>) to investigate the effects of these synthesized compounds on CA isoenzymes. The compounds' <sup>1</sup>H NMR, <sup>13</sup>C NMR, and HRMS spectra were used to confirm their chemical structures. The synthetic derivatives were screened for their inhibitory potential against carbonic anhydrase I and II by <i>in vitro</i> assay. These compounds have IC<sub>50</sub> values of 3.727–1.493 μM (hCA I) and 3.892–1.547 μM (hCA II). Inhibition types and <i>K</i><sub>i</sub> values of the compounds were determined. The <i>K</i><sub>i</sub> values of the compounds were 3.006 ± 0.17 μM-0.356 ± 0.0 μM (hCA I) and 2.923 ± 0.15 μM-0.346 ± 0.0 μM (hCA II). Acetazolamide (AAZ) was used as the reference in the study. The most potent derivatives, a 4-methoxy derivative (compound <b>4k</b>) and 4-(trifluoromethyl) derivative (compound <b>4g</b>), than AAZ (IC<sub>50</sub> = 2.26 μM) and their IC<sub>50</sub> values were found as 1.493 μM and 1.675 μM, respectively. Compared to AAZ, the other derivatives having more effect on hCA I were compounds <b>4b</b>, <b>4e</b>, <b>4l</b>, <b>4m</b>, <b>4n</b>, and <b>4o</b>. The compounds gave IC<sub>50</sub> values of 1.743, 1.789, 1.933, 1.966, 1.983, and 1.986 μM, respectively. Compounds <b>4a-4r</b> found no more effective inhibitory activity against hCA II isozyme than AAZ (IC<sub>50</sub> = 1.17 μM). According to the <i>in vitro</i> test results, detailed protein-ligand interactions of the compounds <b>4b</b> and <b>4k</b> exhibited considerably low binding energies, suggesting strong interaction affinities against hCA I. In addition, the cytotoxic effects of the compounds on the L929 healthy cell line were evaluated.</p>\n </div>","PeriodicalId":143,"journal":{"name":"Chemical Biology & Drug Design","volume":"104 6","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chemical Biology & Drug Design","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cbdd.70025","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

In this study, we propose identifying potential novel compounds targeting carbonic anhydrase I and II. Herein, we have designed and synthesized new benzimidazole-hydrazide-hydrazones derivatives (4a-4r) to investigate the effects of these synthesized compounds on CA isoenzymes. The compounds' 1H NMR, 13C NMR, and HRMS spectra were used to confirm their chemical structures. The synthetic derivatives were screened for their inhibitory potential against carbonic anhydrase I and II by in vitro assay. These compounds have IC50 values of 3.727–1.493 μM (hCA I) and 3.892–1.547 μM (hCA II). Inhibition types and Ki values of the compounds were determined. The Ki values of the compounds were 3.006 ± 0.17 μM-0.356 ± 0.0 μM (hCA I) and 2.923 ± 0.15 μM-0.346 ± 0.0 μM (hCA II). Acetazolamide (AAZ) was used as the reference in the study. The most potent derivatives, a 4-methoxy derivative (compound 4k) and 4-(trifluoromethyl) derivative (compound 4g), than AAZ (IC50 = 2.26 μM) and their IC50 values were found as 1.493 μM and 1.675 μM, respectively. Compared to AAZ, the other derivatives having more effect on hCA I were compounds 4b, 4e, 4l, 4m, 4n, and 4o. The compounds gave IC50 values of 1.743, 1.789, 1.933, 1.966, 1.983, and 1.986 μM, respectively. Compounds 4a-4r found no more effective inhibitory activity against hCA II isozyme than AAZ (IC50 = 1.17 μM). According to the in vitro test results, detailed protein-ligand interactions of the compounds 4b and 4k exhibited considerably low binding energies, suggesting strong interaction affinities against hCA I. In addition, the cytotoxic effects of the compounds on the L929 healthy cell line were evaluated.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
含苯并咪唑环的新型肼腙:CA I和CA II同工酶抑制剂的设计、合成和性能评价
在这项研究中,我们提出鉴定潜在的靶向碳酸酐酶I和II的新化合物。在此,我们设计并合成了新的苯并咪唑-肼-腙衍生物(4a-4r),并研究了这些合成的化合物对CA同工酶的影响。化合物的1H NMR、13C NMR和HRMS谱被用来确定它们的化学结构。通过体外实验筛选合成的碳酸酐酶I和碳酸酐酶II的抑菌活性。化合物的IC50值分别为3.727 ~ 1.493 μM (hCA I)和3.892 ~ 1.547 μM (hCA II)。化合物的Ki值分别为3.006±0.17 μM (hCA I)和2.923±0.15 μM-0.346±0.0 μM (hCA II),以乙酰唑胺(Acetazolamide, AAZ)为参比。4-甲氧基衍生物(化合物4k)和4-(三氟甲基)衍生物(化合物4g)的IC50值分别为1.493 μM和1.675 μM,比AAZ的IC50值为2.26 μM。与AAZ相比,对hCA I影响更大的其他衍生物是化合物4b, 4e, 411, 4m, 4n和40o。所得化合物的IC50分别为1.743、1.789、1.933、1.966、1.983和1.986 μM。化合物4a-4r对hCAⅱ同工酶的抑制活性不高于AAZ (IC50 = 1.17 μM)。根据体外实验结果,化合物4b和4k的详细蛋白质-配体相互作用表现出相当低的结合能,表明对hCA i具有很强的相互作用亲和力。此外,我们还评估了化合物对L929健康细胞系的细胞毒作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Chemical Biology & Drug Design
Chemical Biology & Drug Design 医学-生化与分子生物学
CiteScore
5.10
自引率
3.30%
发文量
164
审稿时长
4.4 months
期刊介绍: Chemical Biology & Drug Design is a peer-reviewed scientific journal that is dedicated to the advancement of innovative science, technology and medicine with a focus on the multidisciplinary fields of chemical biology and drug design. It is the aim of Chemical Biology & Drug Design to capture significant research and drug discovery that highlights new concepts, insight and new findings within the scope of chemical biology and drug design.
期刊最新文献
Cover Image Multi-Omics and Machine Learning-Driven Discovery of ABCC8 (SUR1) for Diabetes Mellitus: Integrating Molecular Insights on Nigella sativa Bioactives and Sulfonylurea Novel Silver(I) and Gold(I) N-Heterocyclic Carbene Complexes Induce ROS-Dependent Autophagic Cell Death in Human Hepatoma Cell Line HepG2 High-Throughput Platform for Discovery of Chemical Inhibitors of Heat Shock Protein 70 (Hsp70): Adaptation for the Specialized Bacterial HscA–HscB–IscU Complex Thiadiazole-Derived VEGFR-2 Inhibitors: From Design to Anticancer Evaluation
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1